MassARRAY® System Selected for Assurex Health’s GeneSight Test SAN DIEGO, Calif., June 20, 2017– Agena Bioscience today announced that Assurex Heath, a wholly owned subsidiary

Published on 15th June 2017 Magstim Group, Inc., the pioneer in trans-cranial magnetic stimulation and intraoperative nerve monitoring, today announced that it has appointed Lothar

Dynex Technologies (Dynex) has been acquired by Telegraph Hill Partners (THP), a leading venture capital and growth equity firm dedicated to the life science and

SAN DIEGO, Calif., March 15, 2017 — Agena Bioscience today introduced new targeted research panels for the detection of somatic mutations from lung and colon

Vancouver, British Columbia, March 8, 2017 – Precision NanoSystems has launched the NanoAssemblr™ Scale-Up system to support the clinical development of nanomedicines. This latest addition

Argonaut Manufacturing Services, a contract manufacturing organization (CMO) dedicated to serving the life science and molecular diagnostics markets, announced today that it has received ISO

AUSTIN, Texas − February 20, 2017 − Asuragen, Inc., a global molecular diagnostics company, announced today that it has entered into a collaboration agreement with Thermo

SAN DIEGO, Calif., February 9, 2017 – Agena Bioscience today announced a comparative study published in Scientific Reports highlighting the use of its mass spec-based

GUILFORD, CT, JANUARY 31, 2017 University of Florida Health Shands Hospital (UF Health Shands) has selected Medpricer Analytics™ to gain additional visibility into their Purchased

CARDIFF, WALES, UK – TrakCel, the leading provider of cellular orchestration technology to aid in the delivery of regenerative therapies, has successfully completed a multi-million

Precision NanoSystems, Inc. (PNI), a global nanomedicine company, has announced the completion of a $13.4 million private Series A financing. The investment was led by

FREMONT, Calif.– (BUSINESS WIRE)–Nitinol Devices & Components, Inc. (“NDC”), announced today it has successfully completed the acquisition of Interface Catheter Solutions (“Interface”). Reflecting the combination’s